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Eosinophilia represents  an  important model  for  the study of the control  of 
hemopoiesis  because  normal  animals  produce  very  few  eosinophils,  although 
large numbers are produced under certain conditions. High production is asso- 
ciated especially with helminthic infections and allergic responses. Although it is 
difficult to attribute a  specific role to a  single type of cell in a  complex disease, 
the  fact  that  eosinophils  are  present  in  large  numbers  and  can  kill  parasitic 
helminths in vitro, suggests they may be important to the defense system against 
these infectious agents. 
Based on  the  demonstration  that  experimentally induced  T  cell  deficiency 
inhibits the development of eosinophilia (1, 2) and reports that athymic (nu/nu) 
mice do not develop a  significant eosinophilia after infection with a  number of 
different parasitic helminths (e.g.,  3 and 4),  it is reasonable to infer that the T 
cell  system controls  the development of eosinophilia.  The  possibility that  this 
control  is  mediated  by  a  lymphokine  was  first  suggested  by  the  ability  of 
lymphocytes in diffusion chambers to induce eosinophilia (1) and, more recently 
(5-8), by observations that supernatants of antigen- or mitogen-stimulated spleen 
cells can induce eosinophil differentiation in vitro. 
For these reasons  we have sought a  lymphokine activity in alloantigen- and 
parasite antigen-reactive T  cell clones isolated from mice undergoing a parasite- 
induced eosinophilia. Coordinate analysis of this eosinophil differentiation activ- 
ity (EDA) with other lymphokine assays indicated that a  lymphokine was being 
detected which was different from interleukin 2 (IL-2), IL-3, or colony-stimulat- 
ing factors assayed by bone marrow proliferation activity (BMPA), although in 
each case T  cell clones produced one or more of these lymphokines in addition 
to EDA. Since a source of EDA free of other lymphokines was desirable, we have 
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produced (9) a series of T  hybrids and selected one that produces EDA but none 
of the other lymphokines so far tested. Fractionation of conditioned media from 
a T  cell clone and the T  cell hybrid has enabled us to show that IL-3 has relatively 
low  EDA,  and  to  identify a  novel  lymphokine provisionally called  eosinophil 
differentiation factor (EDF) of Mr 46,000. This lymphokine is also detectable in 
serum from mice undergoing a parasite-induced eosinophilia. 
This  work  is  based  on  an  assay  for eosinophils  produced  by bone  marrow 
cultures in microplates. To study the production of eosinophils in vitro, we used 
long term bone marrow cultures in flasks. These provide a model system for the 
study  of  eosinophil  differentiation  and  provide  a  source  of  eosinophiis  for 
functional studies.  Our results show that these eosinophils are morphologically 
normal and functional in that they can lyse antibody-coated sheep red blood cells 
(SRBC) and Schistosoma mansoni schistosomula. 
Materials and  Methods 
Parasite.  Second-stage larvae (tetrathyridia) of the cestode Mesocestoides corti Hoeppli 
1925 was used to induce eosinophilia in BALB/c Nimr mice (10). The mice were infected 
by intraperitoneal injection of 100 #1 packed tetrathyridia. Since the larvae reproduce 
asexually in the peritoneum, the parasite can be maintained by serial passage and large 
numbers  obtained  for antigen  preparation.  Soluble parasite  antigen  was  obtained by 
disrupting 1 ml packed tetrathyridia in 5 ml phosphate-buffered saline, pH 7.4 (PBS) at 
4 °C using a Dounce homogenizer. The soluble fraction was removed after centrifugation 
and filter sterilized before storing at -70°C. 
Tissue Culture.  The basic medium consisted of RPMI  1640 containing bicarbonate 
(Gibco Europe, Paisley, Scotland) supplemented with 10 mM Hepes, 2 mM glutamine,  1 
mM sodium pyruvate, and 7.5  X  10  -5  M monothioglycerol (Sigma Chemical Co. Ltd., 
Poole,  Dorset).  The  bone  marrow  cultures  were  further supplemented  with  10  -6  M 
hydrocortisone 21-hemisuccinate sodium salt (Sigma Chemical Co. Ltd.). Preselected fetal 
calf serum  (FCS)  (Sera Lab Ltd., Crawley Down, Sussex) was  used at  10%  for T  cell 
cloning and 15% for bone marrow cultures. Cultures were incubated at 37 °C in a humid 
atmosphere of 5% CO2 in air. 
T Cell Cloning.  Spleens were removed 2 wk after infection with M. corti. Cloning was 
carried out by culturing these spleen cells in limiting dilution, using one plate for each 
dilution.  Parasite antigen-responding clones were obtained by culturing with  2  X  105 
irradiated, T cell-depleted, BALB/c spleen cells per well, an optimum dilution of parasite 
antigen and IL-2 (see below). AIloreactive clones were obtained by culturing with 2 x  105 
irradiated, T cell-depleted CBA Nimr spleen cells per well and IL-2. Irradiated cells were 
obtained by removing the spleens of mice 1 h after irradiation with 1,200 rad from a 6°Co 
source. T  cell depletion was carried out by treatment with monoclonal anti-Thy-I (NIM- 
R1) (11) and guinea pig complement. Cultures were established in  100 #l  of medium. 
After 10 d a further 100 #1 of medium containing IL-2 was added. After 14 d the cells in 
the wells were washed and stimulated as before but without the IL-2. After 24 h clone 
supernatants were collected for the lymphokine assay and replaced with medium contain- 
ing IL-2. 
Experiments were carried out on clones obtained from plates with <30% positive wells. 
Two alloreactive clones (NIMP-T1 and NIMP-T2) were selected for high production of 
EDA and were maintained with IL-2 and restimulation by allogeneic spleen cells every 2 
wk. 
Bone Marrow Cultures.  Femoral bone marrow cells were collected by standard tech- 
niques using bicarbonate-free RPMI  1640 (Gibco Europe) containing 20 mM Hepes and 
5% newborn calf serum (Sera Lab Ltd.). Cultures were established by a modification of 
the method described by Dexter and Testa (12).  Cells were aliquoted (106 cells/ml) into 
24-well  cluster  plates  (1  ml/well;  Costar,  Data  Packaging,  Cambridge,  MA)  or  tissue 62  EOSINOPHIL DIFFERENTIATION FACTOR 
culture flasks (10  ml/25  cm  2 flask;  Nunc,  Roskilde,  Denmark).  At weekly intervals  the 
cultures  were  gently  shaken  and  half the  medium  harvested  and  replaced  with  fresh 
medium.  Nonadherent cells were counted with a  Coulter Counter (Coulter Electronics, 
Inc., Hialeah, FL) and differential counts were performed on Giemsa-stained cytocentri- 
fuge preparations. 
Microplate assays were carried out with 105 (100 tA) bone marrow cells per well (round- 
bottom microplates; Nunc). Test supernatants were added (10 tA) and the plates incubated 
at 37°C. BMPA was assayed by adding [SH]thymidine (see below) at 48 h and harvesting 
the  cells at  64-66  h  (13).  After  5  or 6  d  the  number  of eosinophils  was estimated  by 
assaying eosinophil peroxidase using O-phenylenediamine as hydrogen donor, and reading 
A492 in a Titertek Multiskan (Flow Laboratories Ltd., Irvine, Ayrshire, Scotland). Details 
of this technique and evidence that it is specific for eosinophils are described elsewhere 
(Strath, Warren, and Sanderson, submitted for publication). Alternatively, total cell counts 
were made  by resuspending the cells in the well  and removing 50 #1 for counting in a 
Coulter Counter; differential counts were made by applying 5/~1 to the wells of a  15-well 
multitest slide (Flow Laboratories Ltd.). These slides were prepared by placing 2 IA of 0.1 
mg/ml concanavalin A (Con A) in the wells a few minutes before adding the cell suspension. 
The slides were left at room temperature  for 30-45 min to allow the cells to adhere to 
the Con A-coated glass surface. The slides were then fixed in methanol and stained with 
Giemsa  for  differential  counts.  The  number  of each  cell  type  produced  comprises  a 
myeloid differentiation assay. 
Lymphokine Assays.  IL-2 was assayed on the CTLL cell line (14) by incubating 10 t~l of 
supernatant  with  104 cells  in  100  ~1  media  for 24 h.  During the  final  4  h,  0.5  /~Ci of 
[methyl-~H]thymidine (5 Ci/mmol; Amersham International plc) was added to each well. 
The cells were harvested onto glass fiber filter paper and processed for liquid scintillation 
counting. IL-3 was assayed in the same way on cell line 32D (15). In all these assays, clones 
were scored positive if higher than the control mean plus three standard deviations. 
Hemopoietic Growth Factors.  Conditioned medium from the T  hybrid NIMP-TH1 was 
prepared by stimulating the cells at 5 ×  105/ml with  10 ng/ml phorbol myristate acetate 
(PMA)  (Sigma  Chemical  Co.  Ltd.)  in  medium  containing  5%  FCS  (9).  Cultures  were 
incubated at 37 °C for 48 h and supernatant harvested by centrifugation. After filtration, 
conditioned medium was stored at -20 ° C. BW5147 conditioned medium was prepared 
in an identical manner.  Conditioned media from the alloreactive T  cell clones NIMP-T1 
and NIMP-T2 were prepared by stimulating the T  cells at  105/ml with irradiated  CBA 
spleen cells at  106/ml. 
Conditioned medium was also prepared from an EL4 cell line (16) (kindly supplied by 
Dr. H. R. MacDonald, Ludwig Institute for Cancer Research, Lausanne, Switzerland) by 
stimulating  at  106/ml  for  6-8  h  with  100  ng/ml  of PMA,  washing  three  times,  and 
incubating in fresh medium  for a further 24 h. The supernatant  was collected, filtered, 
and stored at -20°C, and was used at 1-2% as a source of IL-2. 
Conditioned media from the cell lines WEHI-3 (17) and L-929 (18) were used at  10%. 
Mouse lung-conditioned medium was prepared and concentrated (19) and used at 0.1%. 
Functional  Activity  of Eosinophils.  Eosinophils  from  cultures  in  75-cm  2 flasks  were 
enriched  using a  two-step gradient  of 17.25  and  16%  Meterizamide  (Nyegaard (U.K.) 
Ltd., Sheldon), prepared as detailed previously (20). After centrifuging at  1,200 g for 15 
min the cells on the lower interface were removed, washed in medium, and resuspended 
to the required density. 
The  ability  to  lyse  5~Cr-labeled,  trinitrophenyl-coupled  SRBC  (SRBC-TNP)  in  the 
presence  of anti-TNP  monoclonal antibodies  were  determined  as  described  (21);  full 
details of the monoclonal antibodies are given (21).  A  mouse anti-SRBC antiserum was 
used as a positive control at a dilution of 1:20. The ability to kill S. mansoni schistosomula 
was  determined  as  described  (22)  except  that  RPMI  medium  containing  10%  heat- 
inactivated FCS was used. We thank Dr. S. R. Smithers for providing the antiserum and 
Fiona Hackett for preparing the schistosomula (both of this institute). 
Fractionation.  Gel filtration was carried out on two separate columns of ~300 ml bed 
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50 #g/ml polyethylene glycol (PEG 6000; BDH Pharmaceuticals Ltd., Poole, Dorset).  A 
sample volume of 10 or 2 ml was loaded and effluent was collected as 5-ml  fractions. 
Fractions were tested for IL-3 and EDA by adding 10 tA of each fraction (or a dilution of 
each) to the assay plates.  The column was calibrated with: bovine serum albumin, Mr 
66,000;  ovalbumin, Mr 45,000;  carbonic anhydrase, Mr 30,000;  and cytochrome c, Mr 
12,400 (all from Sigma). The correlation between log Mr and elution volume was calculated 
by linear regression and the formula used to calculate Mr for EDA and IL-3. The error 
of Mr determination was very small (r  2 =  1.00).  The Mr range was calculated from the 
width of the elution profile at 50% maximum activity. 
Purified IL-3 was prepared from WEHI-3-conditioned medium (WE-CM) following the 
procedure described by Ihle et al. (17), which uses the following steps:  DEAE cellulose, 
hydroxyapatite, gel filtration on AcA54, and reverse phase, high pressure liquid chro- 
matography on a u-Bondapak C18 column (Waters Associates, Milford, MA). 
Electron Microscopy.  Samples  for transmission electron microscopy were fixed with 
2.5%  glutaraldehyde in  0.09  M  cacodylate buffer,  pH  7.2,  containing 2  mM CaCI~, 
followed by 1% osmium tetroxide in the same buffer, and then 1% uranyl acetate. Samples 
for scanning electron microscopy were sedimented in serum-free PBS to remove nonad- 
hering cells,  and  then allowed to settle on  coverslips  coated with Alcian Blue (Gurr 
Biological Stains, BDH Pharmaceuticals Ltd.). They were then treated sequentially with 
4% paraformaldehyde and 0.25% glutaraidehyde in 0.05  M cacodylate buffer, pH 7.2, 
2% osmium tetroxide, and  1% uranyl acetate. After dehydrating with absolute alcohol 
they were critical point dried above Arklone P (ICI Mond Division, Runcorn, Cheshire) 
and splutter coated with gold. 
Results 
Assays for Hemopoietic Growth Factors.  To  illustrate  the  effect of different 
hemopoietic growth factors on the liquid culture system, and to justify the use 
of bone marrow from parasitized mice in the assay for differentiation factors, we 
tested different sources of hemopoietic growth factors in different assays (Fig. 
1). In a  myeloid differentiation assay, bone marrow from parasitized mice gave 
a  higher  number  of eosinophils  than  normal  bone  marrow.  This  presumably 
reflects the relative paucity of eosinophil precursors  in  normal bone  marrow, 
and makes the assay for EDA more sensitive. The assay for eosinophil peroxidase 
is a  sensitive assay for the number of eosinophils in cultures.  It is important to 
note that the use of bone marrow from parasitized mice did not materially affect 
the ability to detect neutrophil or macrophage differentiation activities present 
in mouse lung- (ML-CM) and L cell- (LC-CM) conditioned media, respectively. 
These data show that the different biological activities present in these sources 
of hemopoietic  growth  factors  can  be  distinguished  using  the  liquid  culture 
systems. For example,  LC-CM  known to contain CSF-M  (macrophage  lineage 
colony-stimulating factor) (CSF1)  had  strong BMPA,  no  IL-3,  and  stimulated 
macrophage differentiation. ML-CM known to contain granulocyte-macrophage 
CSF (CSF-GM) and granulocyte CSF (CSF-G) had BMPA, low IL-3 activity, and 
stimulated mainly neutrophils. Purified IL-3 had activity in the BMPA assay and 
stimulated both  neutrophil  and  macrophage  differentiation with low levels of 
EDA (detectable only by peroxidase assay in this experiment). The T  clone (T2- 
CM) produced IL-3, had strong EDA, and was positive for BMPA. The T  hybrid 
(TH 1-CM) was positive for EDA, had low activity in the BMPA, and was negative 
for IL-3. 
To  investigate  the  relationship  between  IL-3  and  EDA  in  more  detail,  we 
tested dilutions of conditioned media for both activities. The relative activity of 64  EOSINOPHIL  DIFFERENTIATION  FACTOR 
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FIGURE  1.  A  comparison  of different sources  of hemopoietic growth  factors  in  different 
assays.  (Le~) Production of different cell types in a  7 d  liquid culture system in cluster plates 
using normal bone marrow. Total cells were determined in a Coulter Counter; the proportion 
of the different cell types was based on differential counts (error,  1 SD). (11) Eosinophils; (Ill) 
neutrophils; (I--1) mononuclear cells.  Assay for eosinophil peroxidase (A49~) is shown as a small 
box; errors in  this assay  are smaller than  can  be represented  by symbols.  (Middle)  Parallel 
assay using bone marrow from parasitized mice (14 d infection). Details as above. (Right) Assay 
of the same sources of hemopoietic growth factors for 1L-3 (A) and BMPA using normal (O) 
and parasitized (O) bone marrow.  Values to the left of the dotted line are not significantly 
different from control; values to the right are significant at the 0.1% level or greater. 
TABLE  I 
Estimation of EDA Due to IL-3 in Different Conditioned Media 
Calculated*  Estimatedl 
IL-3 units*  EDA due  EDA units~  EDF units  to IL-3 
Purified IL-3  1,749  622  622  0 
WE-CM  65  23  41  18 
TH1-CM  None  0  1,353  1,353 
T2-CM  89  32  1,576  1,544 
* IL-3  units  determined  graphically  as  the  dilution  of the  preparation 
giving 30% of the maximum counts in the IL-3 assay. 
* EDA was assumed to be due to IL-3 in this purified preparation of IL- 
3.  Thus  1  U  of IL-3  produces  0.36  U  of EDA.  Other  values were 
calculated from the IL-3 activity using this constant. 
§ EDA units were determined graphically as the dilution of the proportion 
giving 30% of maximum A49~ in the EDA assay. 
I Putative EDF units after subtracting  the calculated EDA units due to 
IL-3 from the EDA units determined in the assay. 
each  conditioned  medium  was  estimated  graphically  (Table  I).  Thus,  purified 
IL-3 had  1,749  U  of IL-3 and  622  U  of EDA.  Using  this as a  basis,  the EDA  due 
to  IL-3  in  each  sample  was  calculated.  As  seen  in  Table  I,  WE-CM  contained 
little or no  EDA  that could  not  be accounted  for by the  IL-3, whereas  TH1-CM 
and  T2-CM  contained  more  EDA  than  would  be  expected  from  their  IL-3 
activity. 
T  Cell  Clones.  A  series  of  53  parasite  antigen-reactive  T  clones  and  31 SANDERSON,  WARREN,  AND  STRATH  65 
alloantigen-reactive  T  clones were isolated from the spleen of a mouse infected 
with  M.  corti.  After  2  wk  growth,  these  were  restimulated  in  the  absence  of 
exogeneous IL-2 and supernatants were collected after 24 h. These supernatants 
were assayed for IL-2, IL-3, BMPA, and EDA (Fig. 2). 
The  data  for  the  alloreactive  clones  indicate  that  there  is  no  correlation 
between  EDA and BMPA, although the slope for the correlation between  IL-3 
and EDA is significant.  This correlation probably derives from the fact that all 
the clones are positive for IL-3.  There  is a cluster of points negative for EDA 
and low for  IL-3.  However,  some clones high  for  IL-3  are  negative  for EDA, 
making it extremely unlikely  that IL-3 is solely responsible for the EDA.  None 
of  the  parasite  antigen-reactive  clones  produced  detectable  IL-2.  All  gave 
significant EDA, but the correlation with IL-3 or BMPA is not significant. Several 
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FIGURE  2.  Comparison  of different  lymphokine  activities  by  individual  T  cell  clones.  (a) 
Alloreactive clones showing  IL-2 and EDA.  r  =  0.065;  slope,  0.42  _  1.99  (not significant). 
There is clearly no correlation  between  these activities. (b) Antigen-reactive  clones showing 
BMPA and EDA (control mean +_. 3  SD; A401 =  0.3).  All the clones were positive for EDA.  r 
=  0.28;  slope, 0.07  _  0.06 (not significant); thus there was no correlation between these two 
activities. (c) Alloreactive clones showing IL-3 and EDA.  All the clones were positive for IL- 
3. r  =  0.66; slope, 0.11  +  0.04 (significant at  1% level, see text). (d) Antigen-reactive clones 
showing  IL-3 and EDA.  All the clones were positive in both assays, r  =  0.14;  slope,  39.5:1: 
59.5 (not significant); thus there was no correlation between these two activities. 66  EOSINOPHIL  DIFFERENTIATION  FACTOR 
of the alloreactive T  clones have been expanded as sources of EDA, and the high 
activity of two of these and the T  hybrid is shown in Fig. 3. Note also that serum 
from M. corti mice shows high levels of EDA compared with uninfected mice. 
Colony Formation inAgar.  When tested in an agar colony assay using the same 
medium as  used in  liquid culture  (data  not shown),  the T  clone supernatants 
produced granulocyte/macrophage colonies with a few large mixed colonies, but 
small  eosinophil  colonies  were  rarely  seen.  This  was  comparable  to  colonies 
found with WE-CM.  ML-CM produced only neutrophil and neutrophil/macro- 
phage  colonies,  LC-CM produced  largely macrophage colonies, and TH1-CM 
produced no colonies of any type. 
Fractionation  of Samples  Containing EDA.  Fractions tested after passing con- 
ditioned  medium  through  a  gel  filtration column  confirm the  existence  of a 
novel factor controlling eosinophil differentiation (Fig.  4).  First, passing a  20- 
fold-concentrated sample of WE-CM indicated that EDA from this source cor- 
responded to the elution profile of IL-3, with a  mean Mr of 38,000  (Table II). 
In contrast, T2-CM and TH 1-CM contain EDA corresponding to a  mean Mr of 
46,000.  T2~CM also contain IL-3, with an Mr of 26,000, but this is significantly 
smaller in size than IL-3 from WE-CM. Thus, these two lymphokines in T2-CM 
are  readily separated  by  gel  filtration.  The  fractions of TH1-CM  contain  no 
detectable IL-3. 
It should be noted that fractions of WE-CM gave significant EDA only when 
they contained high activity IL-3. Fractions giving <1,000 cps in Fig. 4 had only 
low  levels  of EDA.  Thus,  the  amount of IL-3  in  T2-CM  would  be  virtually 
undetectable  in  the  EDA assay.  The  relatively  low ability of purified  IL-3  to 
induce eosinophil differentiation was also noted in  Fig.  1;  however,  at higher 
concentrations this material had significant EDA. 
Long-term Bone Marrow Cultures.  Preliminary results showed that bone mar- 
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FIGURE 3.  Titration of EDA activity by assaying  for peroxidase (A492). T clones NIMP-TI 
(Q), NIMP-T2 (C)), T hybrid NIMP-TH1 (r-I), mouse serum from M. corti-infected mice, 10 d 
(V) and  1  5 d (V) after infection. Normal mouse serum (A). A range of dilutions of each 
material was tested and the activity is plotted against the percent final concentration in the 
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FIGURE 4.  Conditioned medium was fractionated by gel filtration and the fractions assayed 
for IL-3  and  EDA. (To])) WE-CM  fractions tested for  IL-3  at  10%  (O)  and  1%  (0)  final 
concentration. Fractions tested for EDA at 10% (A). (Middle)  TH 1-CM fractions assayed for 
IL-3 at  10% (O) and EDA at 10% (V) and 1% (V). (Bottom) T2-CM fractions assayed for IL-3 
at  10%  (©) and EDA at  10%  (V) and  1% (V).  In each case, fractions were assayed over the 
total elution volume of the column, but no activities were detected outside the range shown. 
row  from  parasitized  animals  did  not  maintain  eosinophil  production  in  the 
absence  of added  factors.  Eosinophils  disappeared  within  a  week,  although 
neutrophil production continued for many weeks, as in bone marrow cultures 
from  normal  animals  (8).  However,  in  the presence of TH1-CM,  eosinophil 
numbers were maintained for several weeks (Fig. 5), although neutrophii num- 
bers were significantly lower than in control flasks. When addition of conditioned 
medium was  delayed for  1  wk  so  that  eosinophils  in  the  original  inoculum 
disappear, eosinophils reappeared and were produced for at least 6 wk. In this 
experiment eosinophils  represented 90%  or greater of the nonadherent cells 
released into the medium at peak production. In a series of different experiments, 
eosinophils  consistently  represented  >60%  of the  nonadherent  cells.  When 
addition of conditioned medium was delayed beyond 2  wk, fewer eosinophils 
were produced; furthermore, the difference between flasks was very large, with 68  EOSINOPHIL  DIFFERENTIATION  FACTOR 
TABLE  II 
Molecular Weight  Estimates  from Gel Filtration 
Assay  Column 
Source 
WE-CM  TH 1-CM  T2-CM 
IL-3  A  NT  None  25 (19-34) 
B  38 (31-44)  None  27 (23-32) 
Mean, 26 
EDA  A  NT  44 (32-58)  45 (34-72) 
B  35 (28-45)  47 (37-60)  49 (39-62) 
Mean, 46 
Values represent the mean Mr (X 10  -s) and range estimated from the width 
of the elution peak. NT, not tested. Two columns of similar dimensions 
were used, and samples were applied as a  10 ml vol in column A and a 2 
m[ vol in column B. Elution profiles from column B are shown in Fig. 4. 
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FIGURE 5.  Number of eosinophils (a) and neutrophils (b) in the medium of bone marrow 
cultures. TH 1-CM  added at day 0  (<>), 7  (0),  14  (A), and 21  (&); control flasks (0).  Data 
represent geometric mean and standard deviation of three 25-cm  2 flasks  for each group. In 
some cases, errors are smaller than the symbols and have been omitted. Mononuclear cells 
were fairly constant at -  10 ~ per flask. 
some flasks producing almost no eosinophils and other producing large numbers. 
Essentially similar results were obtained with T2-CM  (data not shown), except 
that,  as  shown  in  Fig.  3,  this  conditioned  medium  can  be  used  at  a  lower 
concentration. 
Functional Activity of  Eosinophils Produced In Vitro.  Eosinophils were produced 
in bulk culture with TH 1-CM. The pooled cells contained 75% eosinophils; these 
were separated from neutrophils by centrifugation on Metrizamide. They were 
tested for cytotoxic activity towards SRBC-TNP in the presence of monoclonal 
antibodies  of different isotypes  (Table  III).  Eosinophils  recovered from  the 
peritoneal exudate of M. corti-infected mice were tested in parallel. Eosinophils 
from both sources lysed SRBC in the presence of IgG1, IgG2a, and IgG2b, but 
not IgM, IgA, or IgE. As further evidence of functional activity, these eosinophils 
killed schistosomula in  the presence of antibody or mouse complement, with 
highest levels of killing in the presence of both antibody and complement (Table 
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TABLE  III 
Cytotoxic Activity of Eosinophils Produced In Vitro and In Vivo 
Against SRBC-TNP in the Presence of Monoclonal Antibodies of 
Different Isotypes 
Antibody 
Source of eosinophils 
In vitro  In vivo 
IgG1  14.7"  16.8" 
IgG2a  10.6  18.7 
IgG2b  22.8  6.8 
IgM  2.2 (NS)  0.5 (NS) 
IgA  4.0 (NS)  0.0 (NS) 
IgE  5.1 (NS)  0.8 (NS) 
Anti-SRBC  35.1  20.9 
Control  5.1  0.2 
* Percentage specific 51Cr release calculated as 100 x (100 -  test)/(100  - 
medium) where  medium is the release  in the absence of antibody to 
effectors  (7.7%). NS, Not significantly different from control (eosino- 
phils but no antibody).  All other values are significant at the 1% level 
or greater. 
Eosinophils produced in vitro consisted of 89% eosinophils, 8% neutro- 
phils, 3% mononuclear cells. Eosinophils produced in vivo consisted of 
92%  eosinophils,  7%  neutrophils, 1%  mononuclear cells. Eosinophils 
were used at a ratio of 8:1 SRBC and incubated for 6 h at 37°C. 
TABLE  IV 
Ability of Cultured Eosinophils to Kill Schistosomula In Vitro 
Percent dead schistosomula* 
Eosinophils  No eosinophils 
Antiserum  s  30 + 5  2 --- 1 
Complement  I  15 + 4  0 
Antiserum + complement  41 ___ I  2 -&-- 1 
Control (normal serum)  3 _  2  2 --- I 
* Percentage dead schistosomula determined by methylene blue uptake 
after 16 h incubation (_ 1 SD). The eosinophil preparation was used at 
a ratio of 1,800:1 schistosomula and consisted of 95% eosinophils, 2% 
neutrophils, and 3% mononuclear cells. 
s Heat-inactivated  antiserum from  mice  11  wk after  infection with  S. 
mansoni at a final dilution of 1:100. 
0 Fresh serum from A strain mice (C5 deficient)  at a dilution of 1:10. 
Control tubes contained heat-inactivated  normal mouse serum at  a 
dilution of 1:100. 
Electron Microscopy.  Transmission electron microscopy showed the presence 
of characteristic eosinophil granules with a  crystalline core  (Fig.  6,  left),  some 
immature  granules  lacking  this  core  were  also  present.  Most  cells  contained 
polyribosomes,  endoplasmic  reticulum,  and  well-developed  Golgi  apparatus. 
Scanning electron miroscopy was carried out after 5  min incubation of schisto- 
somula with cultured eosinophils in the presence of immune serum. Fig. 6, right 
shows that even in this short time period a  significant number of eosinophils had 
adhered to the parasite surface. After about half an hour the parasites would be 
completely obscured by adhering eosinophils (not shown). 7O  EOSINOPHIL DIFFERENTIATION FACTOR 
FIGURE 6.  (a) Transmission electron microscopy  of  an eosinophil  produced in vitro. Mature 
granules with crystalline  core (rag). Immature  granules with partly  developed  crystalline  cores 
(irag). Bar represents 1 ~tm. (b) Scanning  electron microscopy  of a schistosomula  with  adhering 
eosinophils  (e), fixed  5 rain after mixing  immune  serum  and eosinophils  with the schistosomula. 
Bar represents l0 #m. 
Discussion 
The basis of this work has been  the ability to produce eosinophils in bone 
marrow cultures (8) and the adaptation of  this to microculture assays for detecting 
eosinophil  differentiation. In  this  system  eosinophils  can  be  detected  either 
morphologically or by assay for peroxidase. This assay is a  simple and specific 
method for detecting eosinophils, in which in vivo and in vitro eosinophils show 
comparable levels of the enzyme (8).  The specificity is due to the low level of 
peroxidase in mouse neutrophils, and possibly also to the low sensitivity of the 
assay for myeloperoxidase. The assay is more sensitive if bone marrow cells from 
parasitized mice are used, but the results in Fig. 1 indicate that other hemopoietic 
factors can be detected, as with normal bone marrow. These data confirm that 
the BMPA assay detects CSF and IL-3, and that purified IL-3 has very low EDA. 
Furthermore, LC-CM containing CSF-M had no significant EDA, and ML-CM 
containing CSF-GM and CSF-G contained only low EDA.  It is important that 
TH 1-CM produced no colonies in agar, indicating that EDF is distinct from the 
characterized CSF. The significant but low BMPA stimulated by TH 1-CM agrees 
with the concept that only cells in the eosinophil lineage are stimulated. 
By a comparison of the EDA and IL-3 activity in purified IL-3, the EDA due 
to IL-3 in different samples could be calculated. These results confirmed that 
purified IL-3 does have EDA, and indicated that the WE-CM probably contains 
only  IL-3.  The  high  levels  of EDA  in  TH1-CM  and  T2-CM  could  not  be 
accounted for by IL-3, suggesting the presence of a novel factor. Also, analysis 
of the lymphokine activity of a  panel  of 53  parasite antigen-reactive and  31 
alloantigen-reactive T  cell clones from M. corti-infected  mice indicate that EDA 
is  not  correlated  with  the  production  of  IL-2,  IL-3,  or  BMPA.  The  close 
relationship between the development of eosinophils and helminthic infections 
is well known; it is interesting that all of the parasite antigen-reactive clones 
produced EDA. This raises the question whether the development of eosinophilia 
is controlled by a specific subset of T  cells capable of producing EDA, which is 
only activated by parasite infections. Experiments are being carried out to test 
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The relative molecular weight of IL-3 from WE-CM is known to be hetero- 
geneous, with Mr values of 28,000 (28 K), 32.5 K, and 41  K (17, 23), although 
the purified material appears to be the lower end of this range.  In this study IL- 
3 from WE-CM appeared to peak at 38 K. However, the IL-3 activity in T2-CM 
had a  mean Mr of 26 K. Thus it appears that the larger species of IL-3 are not 
produced by this T  cell clone. 
The results with the T  clones and the fact that THI  produces no IL-2, IL-3, 
interferon  (IFN),  or CSF  (9) indicate  that  a  unique  lymphokine  is involved in 
eosinophil  differentiation.  The  hybrid  NIMP-TH1  is  a  unique  source of this 
lymphokine,  because it does not produce significant amounts of other lympho- 
kines and can be grown in bulk cultures.  Control experiments have shown that 
the  PMA  used  to  stimulate  the  hybrid  has  no  effect  on  the  EDA  assay  (9). 
Fractionation by gel filtration indicates that the activity in TH 1-CM is due to a 
factor of Mr 46 K, which is provisionally called eosinophil differentiation factor 
(EDF). EDF can be separated from IL-3 (mr 26 K) although high concentrations 
of IL-3  have  some  EDA.  We  were  unable  to  detect  a  factor of Mr  ~5  K  as 
described by Bartelmez et al. (7). 
In long-term bone marrow cultures both T2-CM and TH1-CM stimulate the 
production  of eosinophils,  which can be used in  functional  assays. The  results 
with TH1-CM are particularly significant, as this contains no CSF or IL-3. The 
time  course  of eosinophil  production  has  several  interesting  features:  (a)  As 
discussed  above,  more  eosinophils  are  produced  in  cultures  from  M.  corti- 
infected mice than those from normal mice. This suggests that EDF is acting on 
precursors  present  in  greater  number  in  bone marrow  from  parasitized  mice 
than  in normal  bone marrow.  (b) Eosinophil  production is transient  compared 
with  neutrophil  production  (8),  suggesting  that,  unlike  neutrophil  precursors 
produced in these cultures (24), eosinophil precursors are not being produced 
de novo from stem cells. (c) If the addition of EDF is delayed, allowing eosinophils 
in the inoculum to disappear, they reappear within ~ 1 wk of adding EDF. This 
indicates that differentiation rather  than prolonged survival is taking place. (d) 
However, if addition is delayed beyond 2 wk, the variation in eosinophil produc- 
tion in different flasks is very great,  suggesting that only a  small proportion  of 
precursors have survived. These surviving precursors have considerable potential 
to  divide,  because  in  some  flasks  relatively  large  numbers  of eosinophils  are 
produced. 
At present,  we do not know why NIMP-TH1  does not stimulate  eosinophil 
colonies in  semisolid  media,  when  the  number  of eosinophils  produced  from 
bone  marrow  in  liquid  culture  suggests  that  ~100  colonies of 300  cells each 
should be produced per  105 bone marrow  cells. This result confirms previous 
work (6) which indicated that eosinophil colonies could not be detected in agar 
but that eosinophils were produced in liquid cultures. Clearly, the EDF described 
in the present report could not have been identified if a colony assay rather than 
a liquid culture system had been used. 
Two  functional  assays  have  been  carried  out  on  eosinophils  produced  by 
stimulation  of bone  marrow  cultures  with  NIMP-THl-conditioned  medium. 
First, using monoclonal antibody-coated SRBC, we found that these eosinophils 
can lyse SRBC coated with IgG1, IgG2a, and IgG2b, but not with IgA, IgM, or 72  EOSINOPHIL  DIFFERENTIATION  FACTOR 
IgE (Table III). The level of lytic activity suggests that, at least in this assay, they 
are as active as eosinophils taken from mice. Secondly, these eosinophils can kill 
S. mansoni schistosomula in the presence of an antiserum or fresh A strain mouse 
serum (C5 deficient) as a source of complement. A combination of antisera and 
complement enhanced killing (Table IV).  In comparison with previously pub- 
lished data on mouse eosinophils, eosinophils produced in culture were at least 
as active against schistosomula as were eosinophils in peritoneal exudates (25) or 
liver granulomata of S. mansoni-infected mice (26). 
Electron microscopy of eosinophils produced in culture showed the character- 
istic eosinophil  granules with  crystalline bar.  The  presence of polyribosomes, 
endoplasmic reticulum, and Golgi apparatus, as well as some immature granules, 
and the preponderance of cells with ring-shaped nuclei, suggest that most of the 
eosinophils are not fully mature.  However, the scanning electron microscopy 
and functional assays indicate that fully functional eosinophils are produced in 
the presence of TH 1-CM. 
Although we cannot rule out the possibility that NIMP-TH 1 produces other 
factors stimulating eosinophil differentiation or maturation, preliminary purifi- 
cation steps  suggest  that a  single factor is  involved.  It  seems likely that  EDF 
controls the differentiation of eosinophils  from committed precursor cells  to 
functional eosinophils,  but,  at least in vitro, it does not appear to control the 
production of committed precursors from stem cells. 
Summary 
Factors stimulating eosinophil  differentiation in vitro have been studied by 
means of  a liquid bone marrow culture system in which the number of eosinophils 
is estimated directly by morphology or indirectly by assay for eosinophil peroxi- 
dase. The results show that eosinophil colonies are not formed in agar, empha- 
sizing the importance of the liquid culture system. 
Three types of evidence identify a novel lymphokine, eosinophil-differentiating 
factor (EDF). (a) Coordinate analysis of lymphokine activity in media conditioned 
by a panel of parasite antigen and another panel of alloantigen-reactive T  cell 
clones indicates that EDF is distinct from interleukin 2  (IL-2),  IL-3, and bone 
marrow proliferation activity (BMPA). (b) A  T  hybrid (NIMP-TH1) produces 
EDF but no IL-2, IL-3, interferon, or colony-stimulating factor. (c) Gel filtration 
of conditioned media (CM) indicates that NIMP-TH 1 and a T  clone (NIMP-T2) 
produce EDF (Mr 46,000).  NIMP-T2 also produced IL-3  (Mr 26,000)  but this 
was easily separated from EDF. IL-3 is also shown to have eosinophil differentia- 
tion activity (EDA) but this represents a  very small proportion of the EDA in 
T2-CM. Fractionation of WEHI-3-CM indicates that EDA from this source has 
a similar elution profile to IL-3 (Mr 35-36,000).  Furthermore, a comparison of 
the relative activities in purified IL-3 and WEHI-3-CM indicates that all the EDA 
can be attributed to the IL-3 in the latter. 
EDF is shown to stimulate production of eosinophils in long-term bone marrow 
cultures; the kinetics of eosinophil production suggests that EDF  is acting on 
committed precursors in the bone marrow. The transient nature of eosinophil 
production  suggests  that  precursors  from  multipotential  stem  cells  are  not 
produced.  The  eosinophils  produced  in  these  cultures  are  morphologically SANDERSON, WARREN, AND  STRATH  73 
normal and functional in that they lysed sheep red blood cells coated with IgG1, 
IgG2a, and IgG2b, but not with IgM, IgA, or IgE. In addition, they were capable 
of adhering to and killing Schistosoma mansoni schistosomula. 
We wish to thank Nick A. Lytton for carrying out the electron microscopy. 
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